Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Anopheles gambiae odorant-binding protein 1 (AgamOBP1) is a small, water-soluble protein located in the sensillar lymph of the African malaria mosquito, Anopheles gambiae (UniProt Q8T6S0). It belongs to the classical odorant-binding protein (OBP) family and plays a fundamental role in the insect's peripheral olfactory system by solubilizing and transporting hydrophobic odorants to olfactory receptors (Biessmann et al., 2010). AgamOBP1 is particularly significant for its role in mediating the recognition of indole, a key chemical cue used by female mosquitoes to locate human hosts and suitable oviposition sites (Biessmann et al., 2010). The protein's expression is sexually dimorphic, with higher levels found in females, and is notably down-regulated following a blood meal, highlighting its importance in host-seeking behavior (Justice et al., 2003). As a critical gatekeeper in the mosquito's sensory pathway, AgamOBP1 is a primary target for the development of novel vector control strategies to combat malaria (Rusconi et al., 2012). Synthetic repellents such as DEET and Icaridin exert their effects by binding to the hydrophobic pocket of AgamOBP1, thereby competitively inhibiting the transport of natural attractants and disrupting the olfactory signaling cascade (Tzotzos et al., 2018). Understanding the structural interactions between AgamOBP1 and its ligands allows for the rational design of more potent and long-lasting repellents (Wogulis et al., 2006). Targeting this protein offers a non-lethal approach to reducing human-vector contact and mitigating the transmission of malaria and other mosquito-borne diseases.
Competitive inhibition of odorant binding and transport to olfactory receptors, disrupting the olfactory signaling cascade.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anopheles gambiae odorant-binding protein 1 (AgamOBP1) (AgamOBP1).